“One of the unique things about working with TCS is that you really feel that joint sense of commitment and ownership.”
AstraZeneca is a global, innovation-driven biopharmaceutical company with a presence in more than 100 countries and innovative medicines used by millions of patients worldwide.
It selected TCS as a partner to focus on its core activities and enhance patient safety.
Vita points out how TCS helped AstraZeneca with the standardization of the pharmacovigilance process. TCS relocated and consolidated seven case handling sites across the globe to two sites, providing consistency, something that regulators seek.
Vita highlights that the partnership shared with TCS has been a unique experience and not a typical client-vendor relationship. TCS and AstraZeneca share equal accountability and responsibility toward achieving joint objectives.
Vita explains that one of its reasons for outsourcing was to increase productivity, which did not meet the industry standards. As a result of its partnership with TCS, productivity in case handling has more than doubled. TCS also helped AstraZeneca centralize its processes, bringing about consistency in working with all its providers as well as regulators.